Pharmacokinetics and Molecular Modeling Indicate nAChRα4-Derived Peptide HAEE Goes through the Blood–Brain Barrier
One of the treatment strategies for Alzheimer’s disease (AD) is based on the use of pharmacological agents capable of binding to beta-amyloid (Aβ) and blocking its aggregation in the brain. Previously, we found that intravenous administration of the synthetic tetrapeptide Acetyl-His-Ala-Glu-Glu-Amid...
Main Authors: | Yurii A. Zolotarev, Vladimir A. Mitkevich, Stanislav I. Shram, Alexei A. Adzhubei, Anna P. Tolstova, Oleg B. Talibov, Alexander K. Dadayan, Nikolai F. Myasoyedov, Alexander A. Makarov, Sergey A. Kozin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/6/909 |
Similar Items
-
Tetrapeptide Ac-HAEE-NH<sub>2</sub> Protects α4β2 nAChR from Inhibition by Aβ
by: Evgeny P. Barykin, et al.
Published: (2020-08-01) -
Sulfonium Ligands of the α7 nAChR
by: Nicole A. Horenstein, et al.
Published: (2021-09-01) -
Pathophysiology of nAChRs: Limbic circuits and related disorders
by: Yann S. Mineur, et al.
Published: (2023-05-01) -
Cholinergic receptors on intestine cells of Ascaris suum and activation of nAChRs by levamisole
by: Mark McHugh, et al.
Published: (2020-08-01) -
Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor
by: Anna P. Tolstova, et al.
Published: (2022-10-01)